Elevance Health Q2 2026 EPS beats; raises full-year adjusted EPS guidance to at least $27.00

Elevance Health, Inc.

Operating revenue $49.8B (+0.8% YoY); diluted EPS $6.71, adjusted diluted EPS $7.45 (includes ~$0.80 net below-the-line benefit).
FY 2026 GAAP EPS guidance raised to at least $20.10; adjusted EPS guidance raised to at least $27.00.
Operating cash flow guidance raised to at least $6.0B; Q2 operating cash flow $1.9B.
Health Benefits segment operating margin fell to 2.1% from 3.8% YoY; medical membership ~44.9M, down 469K sequentially.
Quarterly dividend declared $1.72 per share, payable Sept 25, 2026 to holders of record Sept 10, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.